Exicure, Inc. (XCUR)
NASDAQ · Healthcare
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $10.61M
- P/E ratio
- —
- EPS
- —
- Volume
- 496,390
- 52-week high
- —
- 52-week low
- —
- Open
- $1.62
- Day high
- $2.02
- Day low
- $1.56
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $0 | -$4.95M | -$0.79 |
| 2024 | $500K | -$9.7M | -$4.75 |
| 2023 | $0 | -$16.91M | -$10.55 |
| 2022 | $28.83M | -$2.58M | -$0.56 |
| 2021 | -$483K | -$64.1M | -$21.70 |
About Exicure, Inc.
Exicure, Inc. is a biotechnology firm that utilizes its unique spherical nucleic acid (SNA) platform to create therapies for neurological conditions and hair loss. Its primary experimental candidate, SCN9A, is currently undergoing preclinical evaluation for addressing neuropathic and chronic pain. The company has entered into a strategic partnership with AbbVie Inc. to advance SNA-based solutions for various hair loss conditions, under a collaboration, option, and license agreement. Additionally, a separate collaborative effort with Ipsen S.A. aims to investigate, develop, and commercialize novel spherical nucleic acids targeting Huntington's disease and Angelman syndrome. Established in 2011, Exicure's corporate base is located in Chicago, Illinois.
- CEO
- Jungsoo Kim
- Employees
- 2
- Country
- US
- IPO date
- May 22, 2018
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Exicure, Inc.'s stock price today?
- XCUR is trading at $1.89 as of Jul 20, 2026.
- What is Exicure, Inc.'s market cap?
- Exicure, Inc. (XCUR) has a market capitalization of $10.61M.
- Does Exicure, Inc. pay a dividend?
- Exicure, Inc. did not pay a dividend in its most recent reported fiscal year.
- What sector is Exicure, Inc. in?
- Exicure, Inc. operates in the Healthcare sector.